These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 19300617)

  • 21. Ziprasidone for psychotic disorders: a meta-analysis and systematic review of the relationship between pharmacokinetics, pharmacodynamics, and clinical profile.
    Stip E; Zhornitsky S; Moteshafi H; Létourneau G; Stikarovska I; Potvin S; Tourjman V
    Clin Ther; 2011 Dec; 33(12):1853-67. PubMed ID: 22133697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using oral ziprasidone effectively: the food effect and dose-response.
    Citrome L
    Adv Ther; 2009 Aug; 26(8):739-48. PubMed ID: 19669631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medication patterns and costs associated with olanzapine and other atypical antipsychotics in the treatment of bipolar disorder.
    Zhu B; Kulkarni PM; Stensland MD; Ascher-Svanum H
    Curr Med Res Opin; 2007 Nov; 23(11):2805-14. PubMed ID: 17910804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spotlight on olanzapine in bipolar I disorder.
    McCormack PL; Wiseman LR
    CNS Drugs; 2005; 19(6):553-5. PubMed ID: 15963003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ziprasidone for the treatment of acute manic or mixed episodes associated with bipolar disorder.
    Warrington L; Lombardo I; Loebel A; Ice K
    CNS Drugs; 2007; 21(10):835-49. PubMed ID: 17850172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial.
    Potkin SG; Keck PE; Segal S; Ice K; English P
    J Clin Psychopharmacol; 2005 Aug; 25(4):301-10. PubMed ID: 16012271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder.
    Gunasekara NS; Spencer CM; Keating GM
    Drugs; 2002; 62(8):1217-51. PubMed ID: 12010089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ziprasidone: first year experience in a hospital setting.
    Centorrino F; MacLean E; Salvatore P; Kidwell JE; Fogarty KV; Berry JM; Baldessarini RJ
    J Psychiatr Pract; 2004 Nov; 10(6):361-7. PubMed ID: 15583517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder.
    Mandrioli R; Protti M; Mercolini L
    Expert Opin Drug Metab Toxicol; 2015 Jan; 11(1):149-74. PubMed ID: 25483358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term safety and efficacy of ziprasidone in subpopulations of patients with bipolar mania.
    Keck PE; Versiani M; Warrington L; Loebel AD; Horne RL
    J Clin Psychiatry; 2009 Jun; 70(6):844-51. PubMed ID: 19573482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorder.
    Bowden CL
    J Clin Psychiatry; 2005; 66 Suppl 3():12-9. PubMed ID: 15762830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spotlight on ziprasidone in schizophrenia and schizoaffective disorder.
    Gunasekara NS; Spencer CM; Keating GM
    CNS Drugs; 2002; 16(9):645-52. PubMed ID: 12153335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial.
    Bowden CL; Vieta E; Ice KS; Schwartz JH; Wang PP; Versavel M
    J Clin Psychiatry; 2010 Feb; 71(2):130-7. PubMed ID: 20122373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical antipsychotics for bipolar disorder.
    Yatham LN
    Psychiatr Clin North Am; 2005 Jun; 28(2):325-47. PubMed ID: 15826735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials.
    Perlis RH; Welge JA; Vornik LA; Hirschfeld RM; Keck PE
    J Clin Psychiatry; 2006 Apr; 67(4):509-16. PubMed ID: 16669715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risperidone in the treatment of bipolar mania.
    Sajatovic M; Subramoniam M; Fuller MA
    Neuropsychiatr Dis Treat; 2006 Jun; 2(2):127-38. PubMed ID: 19412457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The safety and tolerability of atypical antipsychotics in bipolar disorder.
    Seemüller F; Forsthoff A; Dittmann S; Born C; Bernhard B; Severus WE; Grunze H
    Expert Opin Drug Saf; 2005 Sep; 4(5):849-68. PubMed ID: 16111448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical antipsychotics: newer options for mania and maintenance therapy.
    Vieta E; Goikolea JM
    Bipolar Disord; 2005; 7 Suppl 4():21-33. PubMed ID: 15948764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Olanzapine: a review of its use in the management of bipolar I disorder.
    McCormack PL; Wiseman LR
    Drugs; 2004; 64(23):2709-26. PubMed ID: 15537371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 13-week, randomized double-blind, placebo-controlled, cross-over trial of ziprasidone in bipolar spectrum disorder.
    Patkar AA; Pae CU; Vöhringer PA; Mauer S; Narasimhan M; Dalley S; Loebel A; Masand PS; Ghaemi SN
    J Clin Psychopharmacol; 2015 Jun; 35(3):319-23. PubMed ID: 25882763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.